Pamela Danagher is a seasoned professional in regulatory affairs with extensive experience in the pharmaceutical industry. Currently serving as the Senior Vice President and Head of Regulatory Affairs at Pathalys Pharma since September 2024, Pamela previously held senior roles at Terns Pharmaceuticals and Takeda, where responsibilities included leadership in regulatory affairs and global program oversight. Career highlights include a tenure at Gilead Sciences focusing on HIV and infectious diseases, and contributions to Amgen in nephrology and metabolic diseases. Pamela's background is grounded in a solid educational foundation with an M.Sc. in Biochemistry and Genetics from the University of Ottawa, complemented by a B.Sc. from McGill University and Western University.
This person is not in any teams
This person is not in any offices